GALAXY: Understanding X and Y Variations

The GALAXY study is a registry that aims to learn more about people with sex chromosome aneuploidy (X&Y variations). This study does not involve any treatment. Instead, researchers will collect information from your medical records, such as genetic tests, imaging results, and medications, from clinics across the US. The goal is to gather this information to improve health outcomes and care for individuals with X&Y variations. You can join if you have a genetically-confirmed diagnosis of a sex chromosome aneuploidy condition, are any age, and any gender. The study will look at health conditions from the start of the study for up to 15 years.

Study design
This is an observational study that plans to include up to 5000 participants. It is a registry that collects information from medical records.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Health conditions will be observed from the study start until a condition is seen, for up to 15 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06373861

Generating Advancements Through Longitudinal Analysis in X and Y Variations (GALAXY)

Recruiting
Not specifiedAges 0+Observational
University of Colorado, Denver
~5,000 participants
Updated 2024-04-18 on ClinicalTrials.gov
What's tested:no intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Health Conditions
Measured over From study start until condition observed, up to 15 years
Sex Chromosome Aneuploidy

NCT06373861

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Children's Hospital Colorado

    Aurora, Coloradostudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Shanlee M Davis, MD, PhD · PRINCIPAL_INVESTIGATOR · Children's Hospital Colorado

Opens a ready-to-send draft in your own email app — review before sending.

  • Health ConditionsFrom study start until condition observed, up to 15 years

    Average number of chronic diagnoses per person